Chwilio Deddfwriaeth

Commission Implementing Regulation (EU) 2016/1240Dangos y teitl llawn

Commission Implementing Regulation (EU) 2016/1240 of 18 May 2016 laying down rules for the application of Regulation (EU) No 1308/2013 of the European Parliament and of the Council with regard to public intervention and aid for private storage (Text with EEA relevance)

 Help about what version

Pa Fersiwn

 Help about advanced features

Nodweddion Uwch

Rhagor o Adnoddau

 Help about UK-EU Regulation

Legislation originating from the EU

When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.

Close

Mae hon yn eitem o ddeddfwriaeth sy’n deillio o’r UE

Mae unrhyw newidiadau sydd wedi cael eu gwneud yn barod gan y tîm yn ymddangos yn y cynnwys a chyfeirir atynt gydag anodiadau.Ar ôl y diwrnod ymadael bydd tair fersiwn o’r ddeddfwriaeth yma i’w gwirio at ddibenion gwahanol. Y fersiwn legislation.gov.uk yw’r fersiwn sy’n weithredol yn y Deyrnas Unedig. Y Fersiwn UE sydd ar EUR-lex ar hyn o bryd yw’r fersiwn sy’n weithredol yn yr UE h.y. efallai y bydd arnoch angen y fersiwn hon os byddwch yn gweithredu busnes yn yr UE. EUR-Lex Y fersiwn yn yr archif ar y we yw’r fersiwn swyddogol o’r ddeddfwriaeth fel yr oedd ar y diwrnod ymadael cyn cael ei chyhoeddi ar legislation.gov.uk ac unrhyw newidiadau ac effeithiau a weithredwyd yn y Deyrnas Unedig wedyn. Mae’r archif ar y we hefyd yn cynnwys cyfraith achos a ffurfiau mewn ieithoedd eraill o EUR-Lex. The EU Exit Web Archive legislation_originated_from_EU_p3

Status:

Point in time view as at 01/07/2023.

Changes to legislation:

There are currently no known outstanding effects for the Commission Implementing Regulation (EU) 2016/1240, Appendix II . Help about Changes to Legislation

Close

Changes to Legislation

Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.

[F1 Appendix II U.K.

DETECTION OF RENNET WHEY IN SKIMMED MILK POWDER FOR PUBLIC STORAGE BY DETERMINATION OF CASEINOMACROPEPTIDES HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC) U.K.

1. SCOPE AND FIELD OF APPLICATION U.K.

This method allows detection of rennet whey in skimmed milk powder intended for public storage by determination of the caseinomacropeptides.

2. REFERENCE U.K.

International Standard ISO 707 - Milk and Milk Products - Guidance on sampling.

3. DEFINITION U.K.

The content of rennet whey solids is defined as the percentage by mass as determined by the caseinomacropeptide content by the procedure described.

4. PRINCIPLE U.K.
  • Reconstitution of the skimmed milk powder, removal of fat and proteins with trichloroacetic acid, followed by centrifugation or filtration;

  • Determination of the quantity of caseinomacropeptides (CMP) in the supernatant by high-performance liquid chromatography (HPLC);

  • Evaluation of the result obtained for the samples by reference to standard samples consisting of skimmed milk powder with or without the addition of a known percentage of whey powder.

5. REAGENTS U.K.

All reagents shall be of recognised analytical grade. The water used shall be distilled water or water of at least equivalent purity.

5.1. Trichloroacetic acid solution U.K.

Dissolve 240 g of trichloroacetic acid (CCl 3 COOH) in water and make up to 1 000 ml. The solution should be clear and colourless.

5.2. Eluent solution, pH 6,0 U.K.

Dissolve 1,74 g of dipotassium hydrogen phosphate (K 2 HPO 4 ), 12,37 g of potassium dihydrogen phosphate (KH 2 PO 4 ) and 21,41 g of sodium sulphate (Na 2 SO 4 ) in about 700 ml of water. Adjust, if necessary, to pH 6,0, using a solution of phosphoric acid or potassium hydroxide.

Make up to 1 000 ml with water and homogenise.

Note: The composition of the eluent can be updated to comply with the certificate of the standards or the recommendations of the manufacturer of the column packing material.U.K.

Filter the eluent solution, prior to use, through a membrane filter with a 0,45 μm pore diameter.

5.3. Flushing solvent U.K.

Mix one volume acetonitrile (CH 3 CN) with nine volumes water. Filter the mixture prior to use through a membrane filter with a 0,45 μm pore diameter.

Note: Any other flushing solvent with a bactericidal effect which does not impair the columns' resolution efficiency may be used.U.K.

5.4. Standard samples U.K.
5.4.1. Skimmed milk powder meeting the requirements of this Regulation (i.e. [0]) U.K.
5.4.2. The same skimmed milk powder adulterated with 5 % (m/m) rennet-type whey powder of standard composition (i.e. [5]) U.K.
6. APPARATUS U.K.
6.1. Analytical balance U.K.
6.2. Optional centrifuge capable of attaining a centrifugal force of 2 200  g, fitted with stoppered or capped centrifuge tubes of about 50 ml capacity U.K.
6.3. Mechanical shaker U.K.
6.4. Magnetic stirrer U.K.
6.5. Glass funnels, diameter about 7 cm U.K.
6.6. Filter papers, medium filtration, diameter about 12,5 cm U.K.
6.7. Glass filtration equipment with 0,45 μm pore diameter membrane filter U.K.
6.8. Graduated pipettes allowing delivery of 10 ml (ISO 648, Class A, or ISO/R 835) or a dispensing system capable of delivering 10,0 ml in two minutes U.K.
6.9. Dispensing system capable of delivering 20,0 ml water at ca. 50 °C U.K.
6.10. Thermostatic water bath, set at 25 ± 0,5 °C U.K.
6.11. HPLC equipment, consisting of: U.K.
6.11.1.

Pump

6.11.2.

Injector, hand or automatic, with a 15 to 30 μl capacity

6.11.3.

Two TSK 2 000 -SW columns in series (length 30 cm, internal diameter 0,75 cm) or equivalent columns (e.g. single TSK 2 000 -SWxl, single Agilent Technologies Zorbax GF 250) and a precolumn (3 cm × 0,3 cm) packed with I 125 or material of equivalent effectiveness

6.11.4.

Thermostatic column oven, set at 35 ± 1 °C

6.11.5.

Variable wavelength UV detector, permitting measurements at 205 nm with a sensitivity of 0,008 Å

6.11.6.

Integrator capable of valley-to-valley integration

Note: Working with columns kept at room temperature is possible, but their power of resolution is slightly lower. In that case, the temperature should vary by less than ± 5 °C in any one range of analyses.U.K.

7. SAMPLING U.K.
7.1.Samples shall be taken in accordance with the procedure laid down in International Standard ISO 707. However, [F2the appropriate authority] may use another method of sampling provided that it complies with the principles of the abovementioned standardU.K.

Textual Amendments

7.2.Store the sample in conditions which preclude any deterioration or change in compositionU.K.
8. PROCEDURE U.K.
8.1. Preparation of the test sample U.K.

Transfer the milk powder into a container with a capacity of about twice the volume of the powder, fitted with an airtight lid. Close the container immediately. Mix the milk powder well by means of repeated inversion of the container.

8.2. Test portion U.K.

Weight 2,000 ± 0,001 g of test sample into a centrifuge tube (6.2) or a suitable stoppered flask (50 ml).

8.3. Removal of fat and proteins U.K.
8.3.1. Add 20,0 ml of warm water (50 °C) to the test portion. Dissolve the powder by shaking for five minutes using a mechanical shaker (6.3). Place the tube into the water bath (6.10) and allow to equilibrate to 25 °C U.K.
8.3.2. Add 10,0 ml of the trichloroacetic acid solution (5.1) of ca. 25 °C in two minutes, while stirring vigorously with the aid of the magnetic stirrer (6.4). Place the tube in a water bath (6.10) and leave for 60 minutes U.K.
8.3.3. Centrifuge (6.2) for 10 minutes at 2 200  g, or filter through paper (6.6), discarding the first 5 ml of filtrate U.K.
8.4. Chromatographic determination U.K.
8.4.1. Inject 15 to 30 μl of accurately measured supernatant or filtrate (8.3.3) into the HPLC apparatus (6.11) operating at a flow rate of 1,0 ml of eluent solution (5.2) per minute U.K.

Note 1. Another flow rate may be used, dependent of the internal diameter of the columns used or the instructions of the manufacturer of the column.U.K.

Note 2. Rinse the columns with water during each interruption. Never leave the eluent solution in them (5.2).U.K.

Prior to any interruption of more than 24 hours, rinse the columns with water then wash them with solution (5.3) for at least three hours at a flow rate of 0,2 ml per minute.

8.4.2. The results of chromatographic analysis of the test sample [E] are obtained in the form of chromatogram in which each peak is identified by its retention time RT as follows: U.K.
Peak II: The second peak of the chromatogram having an RT of about 12,5 minutes.
Peak III: The third peak of the chromatogram, corresponding to the CMP, having an RT of 15,5 minutes.

The choice of the column(s) can affect the retention times of the individual peaks considerably.

The integrator (6.11.6) automatically calculates the area A of each peak:

A II : area of peak II,
A III : area of peak III,

It is essential to examine the appearance of each chromatogram prior to quantitative interpretation, in order to detect any abnormalities due either to malfunctioning of the apparatus or the columns, or to the origin and nature of the sample analysed.

If in doubt, repeat the analysis.

8.5. Calibration U.K.
8.5.1. Apply exactly the procedure described from point 8.2 to point 8.4.2 to the standard samples (5.4) U.K.

Use freshly prepared solutions, because CMP degrade in an 8 % trichloroacetic environment. The loss is estimated at 0,2 % per hour at 30 °C.

8.5.2. Prior to chromatographic determination of the samples, condition the columns by repeatedly injecting the standard sample (5.4.2) in solution (8.5.1) until the area and retention time of the peak corresponding to the CMP are constant U.K.
8.5.3. Determine the response factors R by injecting the same volume of filtrates (8.5.1) as used for the samples U.K.
9. EXPRESSION OF RESULTS U.K.
9.1. Method of calculation and formulae U.K.
9.1.1. Calculation of the response factors R: U.K.
Peak II: R II = 100/(A II [0])

where:

R II

=

the response factors of peaks II,

A II [0]

=

the areas of peaks II of the standard sample [0] obtained in 8.5.3.

Peak III: R III = W/(A III [5] – A III [0])

where:

R III

=

the response factor of peak III,

A III [0] and A III [5]

=

the areas of peak III in standard samples [0] and [5] respectively obtained in 8.5.3,

W

=

the quantity of whey in standard sample [5], i.e. 5.

9.1.2. Calculation of the relative area of the peaks in the sample [E] U.K.
  • S II [E] = R II × A II [E]

  • S III [E] = R III × A III [E]

  • S IV [E] = R IV × A IV [E]

where:

S II [E], S III [E], S IV [E]

=

the relative areas of peaks II, III and IV respectively in the sample [E],

A II [E], A III [E]

=

the areas of peaks II and III respectively in the sample [E] obtained in 8.4.2,

R II , R III

=

the response factors calculated in 9.1.1.

9.1.3. Calculation of the relative retention time of peak III in sample [E]: U.K.

RRT III [E] = (RT III [E])/(RT III [5])

where:

RRT III [E]

=

the relative retention time of peak III in sample [E],

RT III [E]

=

the retention time of peak III in sample [E] obtained in 8.4.2,

RT III [5]

=

the retention time of peak III in control sample [5] obtained in 8.5.3.

9.1.4. Experiments have shown that there is a linear relation between the relative retention time of peak III, i.e. RRT III [E] and the percentage of whey powder added up to 10 % U.K.
  • The RRT III [E] is < 1,000 when the whey content is > 5 %;

  • The RRT III [E] is ≥ 1,000 when the whey content is ≤ 5 %.

The uncertainty allowed for the values of RRT III is ± 0,002.

Normally the value of RRT III [0] deviates little from 1,034. Depending on the condition of the columns, the value may approach 1,000, but it shall always be greater.

9.2. Calculation of the percentage of rennet whey powder in the sample: U.K.

W = S III [E] – [1, 3 + (S III [0] – 0,9)]

where:

W

=

the percentage m/m of rennet whey in the sample [E];

S III [E]

=

the relative area of peak III of test sample [E] obtained as in 9.1.2;

1,3

=

represents the relative average area of peak III expressed in grams of rennet whey per 100 g determined in non-adulterated skimmed milk powder of various origins. This figure was obtained experimentally;

S III [0]

=

represents the relative area of peak III which is equal to R III  × A III [0]. These values are obtained in 9.1.1 and 8.5.3 respectively;

(S III [0] – 0,9)

=

represents the correction to be made to the relative average area 1,3 when S III [0] is not equal to 0,9. Experimentally the relative average area of peak III of the control sample [0] is 0,9.

9.3. Accuracy of the procedure U.K.
9.3.1. Repeatability U.K.

The difference between the results of two determinations carried out simultaneously or in rapid succession by the same analyst using the same apparatus on identical test material shall not exceed 0,2 % m/m.

9.3.2. Reproducibility U.K.

The difference between two single and independent results, obtained in two different laboratories on identical test material shall not exceed 0,4 % m/m.

9.4. Interpretation U.K.
9.4.1. Assume the absence of whey if the relative area of peak III, S III [E] expressed in grams of rennet whey per 100 g of the product is ≤ 2,0 + (S III [0] – 0,9) U.K.

where

2,0 is the maximum value allowed for the relative area of peak III taking into account the relative average area of peak III, i.e. 1,3, the uncertainty due to variations in the composition of skimmed milk powder and the reproducibility of the method (9.3.2),
(S III [0] – 0,9) is the correction to be made when the area S III [0] is different from 0,9 (see point 9.2)
9.4.2. If the relative area of peak III, S III [E] is > 2,0 + (S III [0] – 0,9) and the relative area of peak II, S II [E] ≤ 160, determine the rennet whey content as indicated in point 9.2. U.K.
9.4.3. If the relative area of peak III, S III [E] is > 2,0 + (S III [0] – 0,9) and the relative area of peak II, S II [E] ≤ 160, determine the total protein content (P %); then examine graphs 1 and 2. U.K.
9.4.3.1. The data obtained after analysis of samples of unadulterated skimmed milk powders with a high total protein content have been assembled in graphs 1 and 2. U.K.

The continuous line represents the linear regression, the coefficients of which are calculated by the least squares method.

The dashed straight line fixes the upper limit of the relative area of peak III with a probability of not being exceeded in 90 % of cases.

The equations for the dashed straight lines of graphs 1 and 2 are:

S III = 0,376 P % – 10,7 (graph 1),
S III = 0,0123 S II [E] + 0,93 (graph 2),

respectively where:

S III

is the relative area of peak III calculated either according to total protein content or according to the relative area of peak S II [E],

P %

is the total protein content expressed as a percentage, by weight,

S II [E]

is the relative area of sample calculated in point 9.1.2.

These equations are equivalent to the figure of 1,3 mentioned in point 9.2.

The discrepancy (T 1 and T 2 ) between the relative area S III [E] found and the relative area S III is given by means of the following: T 1 = S III [E] – [(0,376 P% – 10,7) + (S III [0] – 0,9)]T 2 = S III [E] – [(0,0123 S II [E] + 0,93) + (S III [0] – 0,9)]

9.4.3.2.
If T 1 and/or T 2 are zero or less, the presence of rennet whey cannot be determined.
If T 1 and T 2 exceed zero, rennet whey is present.

The rennet whey content is calculated according to the following formula: W = T 2 + 0,91

where:

0,91 is the distance on the vertical axis between the continuous and dotted straight lines.]

Yn ôl i’r brig

Options/Help

Print Options

You have chosen to open the Whole Regulation

The Whole Regulation you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.

Would you like to continue?

You have chosen to open Schedules only

Y Rhestrau you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.

Would you like to continue?

Close

Mae deddfwriaeth ar gael mewn fersiynau gwahanol:

Y Diweddaraf sydd Ar Gael (diwygiedig):Y fersiwn ddiweddaraf sydd ar gael o’r ddeddfwriaeth yn cynnwys newidiadau a wnaed gan ddeddfwriaeth ddilynol ac wedi eu gweithredu gan ein tîm golygyddol. Gellir gweld y newidiadau nad ydym wedi eu gweithredu i’r testun eto yn yr ardal ‘Newidiadau i Ddeddfwriaeth’.

Gwreiddiol (Fel y’i mabwysiadwyd gan yr UE): Mae'r wreiddiol version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.

Pwynt Penodol mewn Amser: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.

Close

Gweler y wybodaeth ychwanegol ochr yn ochr â’r cynnwys

Rhychwant ddaearyddol: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.

Dangos Llinell Amser Newidiadau: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.

Close

Dewisiadau Agor

Dewisiadau gwahanol i agor deddfwriaeth er mwyn gweld rhagor o gynnwys ar y sgrin ar yr un pryd

Close

Rhagor o Adnoddau

Gallwch wneud defnydd o ddogfennau atodol hanfodol a gwybodaeth ar gyfer yr eitem ddeddfwriaeth o’r tab hwn. Yn ddibynnol ar yr eitem ddeddfwriaeth sydd i’w gweld, gallai hyn gynnwys:

  • y PDF print gwreiddiol y fel adopted version that was used for the EU Official Journal
  • rhestr o newidiadau a wnaed gan a/neu yn effeithio ar yr eitem hon o ddeddfwriaeth
  • pob fformat o’r holl ddogfennau cysylltiedig
  • slipiau cywiro
  • dolenni i ddeddfwriaeth gysylltiedig ac adnoddau gwybodaeth eraill
Close

Llinell Amser Newidiadau

Mae’r llinell amser yma yn dangos y fersiynau gwahanol a gymerwyd o EUR-Lex yn ogystal ag unrhyw fersiynau dilynol a grëwyd ar ôl y diwrnod ymadael o ganlyniad i newidiadau a wnaed gan ddeddfwriaeth y Deyrnas Unedig.

Cymerir dyddiadau fersiynau’r UE o ddyddiadau’r dogfennau ar EUR-Lex ac efallai na fyddant yn cyfateb â’r adeg pan ddaeth y newidiadau i rym ar gyfer y ddogfen.

Ar gyfer unrhyw fersiynau a grëwyd ar ôl y diwrnod ymadael o ganlyniad i newidiadau a wnaed gan ddeddfwriaeth y Deyrnas Unedig, bydd y dyddiad yn cyd-fynd â’r dyddiad cynharaf y daeth y newid (e.e. ychwanegiad, diddymiad neu gyfnewidiad) a weithredwyd i rym. Am ragor o wybodaeth gweler ein canllaw i ddeddfwriaeth ddiwygiedig ar Ddeall Deddfwriaeth.

Close

Rhagor o Adnoddau

Defnyddiwch y ddewislen hon i agor dogfennau hanfodol sy’n cyd-fynd â’r ddeddfwriaeth a gwybodaeth am yr eitem hon o ddeddfwriaeth. Gan ddibynnu ar yr eitem o ddeddfwriaeth sy’n cael ei gweld gall hyn gynnwys:

  • y PDF print gwreiddiol y fel adopted fersiwn a ddefnyddiwyd am y copi print
  • slipiau cywiro

liciwch ‘Gweld Mwy’ neu ddewis ‘Rhagor o Adnoddau’ am wybodaeth ychwanegol gan gynnwys

  • rhestr o newidiadau a wnaed gan a/neu yn effeithio ar yr eitem hon o ddeddfwriaeth
  • manylion rhoi grym a newid cyffredinol
  • pob fformat o’r holl ddogfennau cysylltiedig
  • dolenni i ddeddfwriaeth gysylltiedig ac adnoddau gwybodaeth eraill